̽��ֱ��

̽��ֱ��ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.

As a young medical student in Nigeria, Segun was shocked by the disproportionate rate of death from treatable cancers across Africa. To help bring...

Cambridge scientists have identified a signature in the blood that could help predict how well an individual will respond to vaccines. ̽��ֱ��discovery...

Previously underexplored immune cell populations have been genetically mapped across multiple tissues to provide new insights into how our immune...

New research provides important insights into the role played by the immune system in preventing – and in some cases increasing the severity of –...

̽��ֱ��drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in...

In late 2019, a new institute opened on the Cambridge Biomedical Campus. Its timing could not have been better - as the COVID-19 pandemic sent...

Six affiliates of the ̽��ֱ�� of Cambridge are among 50 world-leading UK researchers who have been elected to the prestigious Fellowship of the...